Abstract
Hepatoblastomas are the most common liver tumours in children. However, they are rare as compared to other solid malignancies. Thus, there is a need to integrate data from surgical centers around the world to provide a clearer view on the outcomes of multidisciplinary management of these tumours. We set out to retrospectively review our experience of patients with surgically resected hepatoblastomas looking at primary and secondary outcomes. Children diagnosed with hepatoblastoma and managed surgically (along with chemotherapy) at a single institution between 1 January 2000 and 31 May 2007, were analyzed. Out of the 18 patients, there were 12 male and 6 female patients. The median age was 18 months (range 8–72). A palpable mass in abdomen was the presenting symptom in 88% patients. Sixteen patients (88.8%) underwent major liver resection. Sixteen patients (88.8%) received preoperative chemotherapy. Complete gross resection (stage I and II) was achieved in all 18 patients (100%). The mortality and morbidity rates were 0 and 11.2%, respectively. The 80-month disease-free survival was 67%. This series, the largest from India in terms of surgical resections for hepatoblastoma, reaffirms that major liver resection can be performed with minimal perioperative mortality and morbidity and that the use of chemotherapy has definitely helped in down staging tumours for liver resection.
Similar content being viewed by others
References
Christie L, Lang S (2005) Pathology of common childhood tumours. Surgery 23:310–313
Perilongo G, Shafford E, Plaschkes J (2000) SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 1:94–100
Schnater JM, Aronson DC, Plaschkes J et al (2002) Surgical view of the treatment plans of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94:111–1120
Pham TH, Iqbal CW, Grams JM, Zarrug AE, Wall JCH, Ishitani MB, Nagorney DM, Moir C (2007) Outcomes of primary liver cancer in children: an appraisal of experience. J Pediatr Surg 42:834–839
Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, Plaschkes J, Perilongo G (2005) Guidelines for surgical treatment of hepatoblastoma in the modern era—recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41:1031–1036
Fuchs J, Rydzynski J, Hecker J et al (2002) The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma—a report from th German Cooperative Liver Tumours Studies HB89 and HB94. Eur J Pediatr Surg 12:255–261
Udupa KV, Navadgi SM, Mullerpatan P, Chhabra D, Shah RC, Jagannath P (2006). Neoadjuvant chemotherapy before surgery of Hepatoblatoma. Indian J Paediatr 73:735–737
Reynolds M (1999) Pediatric liver tumors. Semin Surg Oncol 16:159–172
Zimmermann A (2005) The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur J Cancer 41:1503–1514
Brown J, Perilongo G, Shafford E et al (2000) pretreatment prognostic factors for children with hepatoblastoma—results from the International Society of Pediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36:1418–1425
Reynolds M (1995) Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study. World J Surg 19:814–816
Schnater JM, Kohler SE, Lamers WH et al (2003) Where do we stand with hepatoblastoma? A review. Cancer 98:668–678
Bajpai M, Pal K, Agarwala S, Seth T, Gupta AK (2005) Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma. Paediatr Surg Int 21:364–368
Andrews W, Sommerauer J, Roden J et al (1996) 10 years experience of pediatric liver transplantation. J Pediatr Surg 31:619–624
Otte JB, Pritchard J, Aronson DC et al (2004) Liver transplantation for hepatoblastoma. Results from the International Society of Pediatric Oncology (SIOP) Study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42:74–83
Takayama T, Makuuchi M, Takayasu K et al (1990) Resection after intraarterial chemotherapy of a hepatoblastoma originating in the caudate lobe. Surgery 107:231–235
Yokomori K, Hori T, Asoh S et al (1991) Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery. J Pediatr Surg 26:844–846
Kitahara S, Makuuchi M, Ishizonw S et al (1995) Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolisation. J Pediatr Surg 30:1709–1712
Han Y-M, Park H-H, Lee J-M et al (1999) Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. J Vasc Intervent Radiol 10:1275–1280
Towu E, Al-Mufti R, Spitz L et al (2002) Upatke of Lipiodol-cytotoxic conjugates by hepatoblastoma cells. Br J Surg 89:437–441
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shukla, P.J., Barreto, S.G., Qureshi, S.S. et al. Hepatoblastoma: a single institutional experience of 18 cases. Pediatr Surg Int 24, 799–802 (2008). https://doi.org/10.1007/s00383-008-2169-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-008-2169-x